Feeney Law Firm is no longer accepting new Xarelto claims

FDA RELEASED FURTHER SAFETY INFORMATION;

"NO ANTIDOTE FOR XARELTO!

SYMPTOMS OF BLOOD LOSS SHOULD BE EVALUATED IMMEDIATLEY."

• Xarelto has also been linked to:
  • Gastrointestinal bleeding
  • Cerebral hemorrhage
  • Excessive menstrual bleeding
  • Excessive nose bleeds
  • Unexplained bruising
  • GI discomfort
  • Blood in stool and/or urine
• According to the Milwaukee Journal Sentinel, more than 58,000 people have reported a serious side effect associated with Xarelto, Pradaxa and Eliquis use.
• In 2014, Boehringer Ingelheim, the manufacturer of Pradaxa, a similar blood thinner, agreed to a $650 million settlement to compensate Pradaxa victims and their families.

The manufacturer of Xarelto ACTED NEGLIGENTLY

• They failed to provide adequate warnings about the risks of taking Xarelto.
• They failed to release the drug with an antidote, meaning that once a bleed develops, doctors may have no way to stop the bleed.
• They used deceptive marketing practices which did not take into account patient safety.